Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The new research focused specifically on associations between background parenchymal enhancement—a known risk factor for breast cancer, visualized on surveillance MRI exams—and secondary breast cancers.
MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected.
Nearly 20% of the women included in the study did not complete their follow-up imaging at all, and out of the 3,648 women who did adhere to additional imaging, 23.3% delayed their exams beyond the recommended 60-day period.
Experts arrived at this conclusion after comparing incidents of hematoma between patients who did and did not receive antithrombotic therapy prior to their procedure.
The authors of the new study noted that, even before the pandemic, consultant breast radiologists were among the most in-demand specialists. The loss of interest in it as a specialty due to COVID will inevitably pose further challenges for recruitment.
Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains how radiology vendors have developed AI app stores to make it easier to access new FDA cleared AI algorithms.
Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains 5 developments to watch for in radiology artificial intelligence (AI).
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
